MedTrace Logo

A Pilot Study for Adaptation of Neospot Device for Health Care at Primary Health Facilities in Kenya

NCT06132633 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 159

Last updated 2023-11-15

No results posted yet for this study

Summary

Neospot device is a 5-in-1 wearable vital signs monitor designed to measure temperature, blood pressure, pulse rate (PR), respiratory rate (RR) and blood oxygen saturation (SPO2). We propose to study the experiences of patients and nurses regarding spot measurement of vital signs at the outpatient department in primary care facilities in Kenya. The study aims to investigate the capability, opportunity, and motivation of nurses to use the Neospot device for vital signs measurement in level 3 facilities in Kenya by validating the accuracy of the Neospot and assessing the experience of patients while using the Neospot, the study also aims to assess the experiences of nurses as they use the Neospot and determine how the Neospot affects their workflow.

Conditions

  • Morbidity

Interventions

DEVICE

Neospot vitals measurement

Vitals of participants in the intervention group will be measured using neospot alongside standard of care measurement.

Sponsors & Collaborators

  • Amref Health Africa

    collaborator OTHER

  • Neopenda, PBC

    lead INDUSTRY

Principal Investigators

  • Jesse Oyieke · Amref International University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-31
Primary Completion
2024-02-29
Completion
2024-04-30

Countries

  • Kenya

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06132633 on ClinicalTrials.gov